{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:02:37Z","timestamp":1790226157893,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hematopoietic cell transplantation is a curative therapy for certain hematologic malignancies but is limited in use due to post-transplant complications such as graft-versus-host disease (GVHD), wherein donor cells mount an immune response against host tissues. GVHD is a major cause of post-transplant mortality, inspiring the development of prophylactic strategies to reduce GVHD severity. However, these involve administration of cytotoxic or immunosuppressive compounds into patients, increasing adverse side effects. To address this issue, we have developed a strategy to reduce GVHD through ex vivo graft conditioning. Previously we demonstrated that pretreatment of mouse grafts with a single compound, fluticasone propionate, dramatically reduced GVHD symptoms after allogeneic transplantation. Here, we condition grafts in a combination of fluticasone propionate, venetoclax, and IL-2 for 6 hours ex vivo prior to transplantation. We demonstrate that the preconditioning process increases the frequency of tolerogenic regulatory T cells pre- and post-transplant. Recipient mice receiving conditioned cells display reduced GVHD severity and increased overall survival in both fully mismatched and haploidentical models. This study highlights an alternative strategy to GVHD prophylaxis which reduces reliance on the administration of toxic compounds.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1746010","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:40:01Z","timestamp":1790224801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Short term ex vivo graft conditioning with venetoclax, fluticasone propionate, and IL-2 reduces graft versus host disease in mouse allogeneic hematopoietic cell transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"L. Angel","family":"Ayala","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alizeh","family":"Ahmedani","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella L.","family":"Hisoire","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexii","family":"Villamar","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Baez","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Onofre","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanel","family":"De Smet","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline U.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Scarfone","sequence":"additional","affiliation":[{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika S.","family":"Varady","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Daud","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Inlay","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, University of California, Irvine","place":["Irvine, CA, United States"]},{"name":"Sue and Bill Gross Stem Cell Research Center, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.05.014","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy - a report from the CIBMTR","volume":"8","author":"Spellman","year":"2025","journal-title":"Transpl Cell Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"409.e1","DOI":"10.1016\/j.jtct.2022.04.012","article-title":"Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes","volume":"28","author":"Phelan","year":"2022","journal-title":"Transplant Cell Ther Off Publ Am Soc Transplant Cell Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199603060-00005","article-title":"The graft-versus-leukemia effect","volume":"3","author":"Mavroudis","year":"1996","journal-title":"Curr Opin Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1268","article-title":"Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation","volume":"101","author":"Asai","year":"1998","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004073","article-title":"Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI","volume":"5","author":"Schultze-Florey","year":"2021","journal-title":"Blood Adv"},{"key":"B7","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current concepts and advances in graft-versus-host disease immunology","volume":"39","author":"Hill","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100792","article-title":"Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions","volume":"48","author":"Martinez-Cibrian","year":"2021","journal-title":"Blood Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1991.tb01406.x","article-title":"A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological Malignancy","volume":"21","author":"Atkinson","year":"1991","journal-title":"Aust N Z J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.105","article-title":"Corticosteroids in the prevention of graft-vs-host disease after allogeneic myeloablative stem cell transplantation: a systematic review and meta-analysis","volume":"22","author":"Quellmann","year":"2008","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202317748","article-title":"Graft conditioning with fluticasone propionate reduces graft-versus-host disease upon allogeneic hematopoietic cell transplantation in mice","author":"Varady","year":"2023","journal-title":"EMBO Mol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-4430-0_12","article-title":"Mass cytometry immunophenotyping of graft-conditioned cells following major histocompatibility complex mismatched murine allograft","volume":"2907","author":"Ayala","year":"2025","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-4430-0_11","article-title":"Flow cytometry analysis of graft conditioning on the T-cell response in graft-versus-host disease following murine allogeneic transplantation","volume":"2907","author":"Ayala","year":"2025","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00010","article-title":"Simple, reproducible, and efficient clinical grading system for murine models of acute graft-versus-host disease","volume":"9","author":"Naserian","year":"2018","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301843200","article-title":"Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis*","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(00)00728-4","article-title":"Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1","volume":"10","author":"Dijkers","year":"2000","journal-title":"Curr Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/me.2010-0402","article-title":"Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17\u223c92 contributes to the induction of Bim and initiation of apoptosis","volume":"25","author":"Molitoris","year":"2011","journal-title":"Mol Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042166","article-title":"FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop","volume":"7","author":"L\u00fctzner","year":"2012","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.09.030","article-title":"Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis","volume":"36","author":"Kim","year":"2009","journal-title":"Mol Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-020-01629-x","article-title":"Regulatory T cells are less sensitive to glucocorticoid hormone induced apoptosis than CD4+ T cells","volume":"25","author":"Prenek","year":"2020","journal-title":"Apoptosis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2649","article-title":"Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells","volume":"14","author":"Pierson","year":"2013","journal-title":"Nat Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2021.03.020","article-title":"A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance","volume":"54","author":"Dikiy","year":"2021","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4298","article-title":"Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment","volume":"23","author":"Guo","year":"2017","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1638176","article-title":"Clinical efficacy and safety of venetoclax combined with hypomethylating agents in relapsed high-risk acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Cheng","year":"2025","journal-title":"Front Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011964","article-title":"Risk of infectious adverse events of venetoclax therapy for hematologic Malignancies: a systematic review and meta-analysis of RCTs","volume":"8","author":"Prosty","year":"2023","journal-title":"Blood Adv"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-044529","article-title":"In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation","volume":"109","author":"Nguyen","year":"2006","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1746010\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:40:10Z","timestamp":1790224810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1746010\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2026.1746010"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1746010","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1746010"}}